Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Nov;30(5):717–723. doi: 10.1111/j.1365-2125.1990.tb03841.x

End-stage renal disease and non-narcotic analgesics: a case-control study.

M Morlans 1, J R Laporte 1, X Vidal 1, D Cabeza 1, P D Stolley 1
PMCID: PMC1368172  PMID: 2271370

Abstract

1. To assess the risk of end-stage renal disease (ESRD) associated with the regular use of three classes of non-narcotic analgesics, we performed a case-control study of 340 patients with ESRD on a haemodialysis maintenance program and 673 hospital controls. 2. The overall odds ratio estimate for non-narcotic analgesics taken at least every other day for 30 days or longer before the first symptom of renal disease was 2.89 (95% CI, 1.78 to 4.68). 3. The risk increased in relation to the use duration. 4. The previous regular consumption of combinations containing phenacetin was strongly associated with ESRD (odds ratio, 19.05; 95% CI, 2.31 to 157.4). The odds ratio for previous regular consumption of salicylates was 2.54 (95% CI, 1.24 to 5.20) and for pyrazolones 2.16 (95% CI, 0.87 to 5.32). 5. An analysis for possible confounding by a history of repeated headaches, arthritis, kidney stones, hypertension, and diabetes did not alter the results. 6. The odds ratio estimates for different pathological subgroups of ESRD patients in relation to previous use of any non-narcotic analgesic were glomerulonephritis. 10.57 (95% CI, 1.25 to 89.0), interstitial nephritis, 3.33 (95% CI, 1.21 to 9.17), cystic kidney disease, 0.71 (95% CI, 0.25 to 1.97), and unknown, 5.15 (95% CI, 2.29-11.57). 7. The results of this study suggest that the regular consumption of analgesics should be routinely considered as a risk factor for any non-congenital cause of chronic renal failure. They also suggest that the risk of ESRD associated with the regular consumption of phenacetin is much higher than the risk associated with other non-narcotic analgesics.

Full text

PDF
723

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELSSON U. Papillitis necroticans renalis och hemolytisk anemi hos fenazonmissbrukare. Nord Med. 1958 Jun 26;59(26):903–904. [PubMed] [Google Scholar]
  2. Bennett W. M., DeBroe M. E. Analgesic nephropathy--a preventable renal disease. N Engl J Med. 1989 May 11;320(19):1269–1271. doi: 10.1056/NEJM198905113201908. [DOI] [PubMed] [Google Scholar]
  3. Brown D. M., Hardy T. L. Short-term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br J Pharmacol Chemother. 1968 Jan;32(1):17–24. doi: 10.1111/j.1476-5381.1968.tb00424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dubach U. C., Rosner B., Pfister E. Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med. 1983 Feb 17;308(7):357–362. doi: 10.1056/NEJM198302173080703. [DOI] [PubMed] [Google Scholar]
  5. EKNOYAN G., MATSON J. L. ACUTE RENAL FAILURE CAUSED BY AMINOPYRINE. JAMA. 1964 Dec 7;190:934–935. doi: 10.1001/jama.1964.03070230070026. [DOI] [PubMed] [Google Scholar]
  6. Gault M. H., Wilson D. R. Analgesic nephropathy in Canada: clinical syndrome, management, and outcome. Kidney Int. 1978 Jan;13(1):58–63. doi: 10.1038/ki.1978.8. [DOI] [PubMed] [Google Scholar]
  7. Gonwa T. A., Hamilton R. W., Buckalew V. M., Jr Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy. Arch Intern Med. 1981 Mar;141(4):462–465. [PubMed] [Google Scholar]
  8. Lachmann D. Spasmoplus -Intoxikation im Säuglingsalter (Erfolgreiche Behandlung durch Austauschtransfusion) Padiatr Padol. 1977;12(1):95–98. [PubMed] [Google Scholar]
  9. Modan B., Boichis H., Bott-Kanner G., Barell V., Bar-Noach N., Eliahou H. E. An epidemiologic study of renal failure. I. The need for maintenance hemodialysis. Am J Epidemiol. 1975 Apr;101(4):276–280. doi: 10.1093/oxfordjournals.aje.a112095. [DOI] [PubMed] [Google Scholar]
  10. Murray T. G., Goldberg M. Analgesic-associated nephropathy in the U.S.A.: epidemiologic, clinical and pathogenetic features. Kidney Int. 1978 Jan;13(1):64–71. doi: 10.1038/ki.1978.9. [DOI] [PubMed] [Google Scholar]
  11. Murray T. G., Stolley P. D., Anthony J. C., Schinnar R., Hepler-Smith E., Jeffreys J. L. Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med. 1983 Sep;143(9):1687–1693. [PubMed] [Google Scholar]
  12. Murray T., Goldberg M. Chronic interstitial nephritis: etiologic factors. Ann Intern Med. 1975 Apr;82(4):453–459. doi: 10.7326/0003-4819-82-4-453. [DOI] [PubMed] [Google Scholar]
  13. Nelson D. A., Berry R. G. Neurological manifestations of antipyrine poisoning. Del Med J. 1967 Mar;39(3):57–63. [PubMed] [Google Scholar]
  14. Ortuno J., Botella J. Recurrent acute renal failure induced by phenazone hypersensitivity. Lancet. 1973 Dec 29;2(7844):1473–1476. doi: 10.1016/s0140-6736(73)92733-5. [DOI] [PubMed] [Google Scholar]
  15. Pommer W., Bronder E., Greiser E., Helmert U., Jesdinsky H. J., Klimpel A., Borner K., Molzahn M. Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol. 1989;9(5):403–412. doi: 10.1159/000168002. [DOI] [PubMed] [Google Scholar]
  16. Pommer W., Bronder E., Klimpel A., Molzahn M., Helmert U., Greiser E. Regular intake of analgesic mixtures and risk of end-stage renal failure. Lancet. 1989 Feb 18;1(8634):381–381. doi: 10.1016/s0140-6736(89)91750-9. [DOI] [PubMed] [Google Scholar]
  17. Prescott L. F. Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs. 1982 Jan-Feb;23(1-2):75–149. doi: 10.2165/00003495-198223010-00004. [DOI] [PubMed] [Google Scholar]
  18. SPUHLER O., ZOLLINGER H. U. Die chronisch-interstitielle Nephritis. Z Klin Med. 1953;151(1):1–50. [PubMed] [Google Scholar]
  19. Sandler D. P., Smith J. C., Weinberg C. R., Buckalew V. M., Jr, Dennis V. W., Blythe W. B., Burgess W. P. Analgesic use and chronic renal disease. N Engl J Med. 1989 May 11;320(19):1238–1243. doi: 10.1056/NEJM198905113201903. [DOI] [PubMed] [Google Scholar]
  20. Vanherweghem J. L., Even-Adin D. Epidemiology of analgesic nephropathy in Belgium. Clin Nephrol. 1982 Mar;17(3):129–133. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES